SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-24-041196
Filing Date
2024-03-29
Accepted
2024-03-29 17:00:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm249997d3_defa14a.htm DEFA14A 39660
2 GRAPHIC tm249997d3_def14aimg001.jpg GRAPHIC 9028
  Complete submission text file 0001104659-24-041196.txt   53304
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 7814399100
Kiniksa Pharmaceuticals, Ltd. (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38492 | Film No.: 24804660
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)